Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Ferric Carboxymaltose vs Oral Ferrous Fumarate for Anemia in Cancer Patients Undergoing Major Elective Surgery
TCTR20251229004Phase 3Not yet recruiting
- Sponsor
- Faculty of Medicine, Chiang Mai University
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ferric carboxymaltose, ferrous fumarate in anaemia, cancer, sponsored by Faculty of Medicine, Chiang Mai University. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
ferric carboxymaltoseferrous fumarate
03
Conditions
anaemiacancer
Beyond the preview
Go deeper on TCTR20251229004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251229004.